Narcolepsy is not associated with increased risk for mortality of any type, even among patients with a higher prevalence of psychiatric comorbidities, new research shows.
VTRS acquires Aculys Pharma to boost its CNS portfolio in Japan, gaining rights to pitolisant and Spydia for narcolepsy and ...
Strengthens Viatris' Presence in Japan With the Addition of Two Innovative Assets Targeting Areas of Significant Unmet Medical Need Leverages Existing ...
Drivers could be prosecuted for not informing the DVLA about changes to their health if they get into an accident ...
Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.
TipRanks on MSN
Viatris completes acquisition of Aculys Pharma
Viatris (VTRS) announced it has acquired Aculys Pharma, a clinical stage biopharmaceutical company focused on commercializing innovative ...
Pittsburgh: Viatris Inc., a global healthcare company, has announced it has acquired Aculys Pharma, Inc., a clinical-stage ...
A warning has been issued over 188 medical conditions which could affect your ability to drive. Failing to report certain medical conditions to the DVLA could result in a fine of up to 1,000. The DVLA ...
Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback